Compare GMED & ENSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GMED | ENSG |
|---|---|---|
| Founded | 2003 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 12.2B |
| IPO Year | 2012 | 2007 |
| Metric | GMED | ENSG |
|---|---|---|
| Price | $86.16 | $202.92 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 5 |
| Target Price | $100.42 | ★ $202.60 |
| AVG Volume (30 Days) | ★ 947.4K | 280.5K |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 0.13% |
| EPS Growth | ★ 422.67 | 14.06 |
| EPS | 3.92 | ★ 5.84 |
| Revenue | $2,938,931,000.00 | ★ $5,057,841,000.00 |
| Revenue This Year | $11.13 | $17.07 |
| Revenue Next Year | $6.28 | $9.49 |
| P/E Ratio | ★ $21.94 | $34.28 |
| Revenue Growth | 16.65 | ★ 18.72 |
| 52 Week Low | $51.79 | $118.73 |
| 52 Week High | $101.40 | $218.00 |
| Indicator | GMED | ENSG |
|---|---|---|
| Relative Strength Index (RSI) | 43.26 | 46.82 |
| Support Level | $85.61 | $202.65 |
| Resistance Level | $87.77 | $215.95 |
| Average True Range (ATR) | 2.02 | 5.14 |
| MACD | -0.14 | -1.92 |
| Stochastic Oscillator | 26.25 | 30.17 |
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.